Dr Mark Watson is Head of Programmes at Clinical Research Development Ireland
(CRDI; formerly Molecular Medicine Ireland), an Investigator in CÚRAM, the SFI Centre for Research in Medical Devices, and a Co-Director of the Wellcome - HRB Irish Clinical Academic Training programme.
Clinical Research Development Ireland is a not-for-profit partnership of Trinity College Dublin, NUI Galway, University College Dublin, the Royal College of Surgeons in Ireland and University College Cork, with the objective of accelerating the translation of biomedical research into improved diagnostics, therapies and devices for patients. CRDI develops and supports collaborations that are building the infrastructures and environment for translational/clinical research and precision medicine.
Mark Watson joined the forerunner of CRDI and MMI, the Dublin Molecular Medicine Centre, in 2003. In the ensuing years, Mark and his team have worked with the partners to win funding for, develop and deliver widely-available short courses, innovative structured PhD programmes and shared resources to support translational and clinical research. He was acting Chief Executive of MMI from October 2012 to March 2013.
Before moving to Ireland Mark worked for the Wellcome Trust, based in the Sanger Institute Cambridge, organising international competitive entry practical courses for researchers. Mark graduated in biological sciences in 1990, after a career in the commercial sector. His postgraduate and postdoctoral research, as a Wellcome Prize PhD Student and Wellcome Research Fellow, focused on understanding complexes that carry out critical cellular functions such as DNA transposition and RNA splicing.